Fu C - Search Results

1

Effects of ginseng berry saponins from panax ginseng on glucose metabolism of patients with prediabetes: A randomized, double-blinded, placebo-controlled, crossover trial.

Gao J, Shi J, Ma X, Lu F, Fu C, Chen Z, Miao L, Qu H, Zhao Y, Zhang Y, Yang Z, Pan D, Zhu C, Li Q, Shi D. Gao J, et al. Among authors: fu c. Phytomedicine. 2024 Sep;132:155842. doi: 10.1016/j.phymed.2024.155842. Epub 2024 Jul 4. Phytomedicine. 2024. PMID: 39004031 Clinical Trial.

2

[Analysis of relationships among syndrome, therapeutic treatment, and Chinese herbal medicine in patients with coronary artery disease based on complex networks].

Gao ZY, Zhang JC, Xu H, Shi DZ, Fu CG, Qu D, Zhou XZ. Gao ZY, et al. Zhong Xi Yi Jie He Xue Bao. 2010 Mar;8(3):238-43. doi: 10.3736/jcim20100307. Zhong Xi Yi Jie He Xue Bao. 2010. PMID: 20226145 Chinese.

3

Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter Study.

Wang SL, Wang CL, Wang PL, Xu H, Liu HY, Du JP, Zhang DW, Gao ZY, Zhang L, Fu CG, Lü SZ, You SJ, Ge JB, Li TC, Wang X, Yang GL, Liu HX, Mao JY, Li RJ, Chen LD, Lu S, Shi DZ, Chen KJ. Wang SL, et al. Evid Based Complement Alternat Med. 2013;2013:741518. doi: 10.1155/2013/741518. Epub 2013 Jul 2. Evid Based Complement Alternat Med. 2013. PMID: 23935679 Free PMC article.

4

Multifactor dimensionality reduction analysis of the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease.

Jiao Y, Li SW, Shang QH, Fu CG, Gao ZY, Xu H, Shi DZ, Chen KJ. Jiao Y, et al. Chin J Integr Med. 2014 May;20(5):341-6. doi: 10.1007/s11655-014-1831-5. Epub 2014 Mar 6. Chin J Integr Med. 2014. PMID: 24599819

5

Complex networks approach for analyzing the correlation of traditional chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease.

Gao Z, Li S, Shang Q, Jiao Y, Zhou X, Fu C, Xu H, Shi D, Chen K. Gao Z, et al. Among authors: fu c. Evid Based Complement Alternat Med. 2015;2015:824850. doi: 10.1155/2015/824850. Epub 2015 Mar 3. Evid Based Complement Alternat Med. 2015. PMID: 25821500 Free PMC article.

6

Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.

Wang SL, Wang CL, Wang PL, Xu H, Du JP, Zhang DW, Gao ZY, Zhang L, Fu CG, Chen KJ, Shi DZ. Wang SL, et al. Exp Biol Med (Maywood). 2016 Mar;241(5):478-84. doi: 10.1177/1535370215617563. Epub 2015 Nov 18. Exp Biol Med (Maywood). 2016. PMID: 26585407 Free PMC article.

7

Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial.

Wang PL, Zhang L, Wang SL, Yang QN, Gao ZY, Du JP, Zhang DW, Fu CG, Gu F, Xu H, Li LZ, Wang CL, Shi DZ. Wang PL, et al. Chin J Integr Med. 2017 Oct;23(10):740-746. doi: 10.1007/s11655-016-2608-9. Epub 2016 Oct 24. Chin J Integr Med. 2017. PMID: 27778264 Clinical Trial.

8

Diagnostic criterion of blood stasis syndrome for coronary heart disease : Activating Blood Circulation Committee of Chinese Association of Integrative Medicine.

Chen KJ, Shi DZ, Fu CG, Gao ZY, Xu H, Lv SZ, You SJ, Huang L. Chen KJ, et al. Chin J Integr Med. 2016 Nov;22(11):803-804. doi: 10.1007/s11655-016-2273-z. Epub 2016 Oct 26. Chin J Integr Med. 2016. PMID: 27783323 No abstract available.

9

Prediction of the Network Pharmacology-Based Mechanism for Attenuation of Atherosclerosis in Apolipoprotein E Knockout Mice by Panax notoginseng Saponins.

Long L, Yu Z, Qu H, Wang N, Guo M, Zhou X, Fu C, Gao Z. Long L, et al. Among authors: fu c. Evid Based Complement Alternat Med. 2020 Apr 22;2020:8574702. doi: 10.1155/2020/8574702. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32382308 Free PMC article.

10

Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial.

Guo M, Wang P, Du J, Fu C, Yang Q, Gao Z, Zhu M, Lv S, Deng Y, Li T, Shi D, Working Group FTX. Guo M, et al. Among authors: fu c. Pharmacol Res. 2020 Aug;158:104883. doi: 10.1016/j.phrs.2020.104883. Epub 2020 May 22. Pharmacol Res. 2020. PMID: 32446979 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,092 results

Search Page

Filters